Latest filing published 18 Dec 2024 for 에스엘에스바이오.
이영태: trading record in brief
All filings by 이영태 on record concern 에스엘에스바이오. Over a trading history stretching from 30 December 2021 to 16 December 2024, the count stands at 8 filings.
On the market, this insider has only ever bought: 8 purchases. The totals do not cover 8 filings with an undisclosed amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. In 2024 alone, the filings show 5 purchases and no sales.
The 8 purchases reviewed show no overlap with other insiders buying the same stock within a month.
Most recently, on 18 December 2024, the filings show an open-market purchase in 에스엘에스바이오. Typically, a trade is published a median of 6 days after it takes place. That lag is the time during which only the insider knows about the trade. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to 이영태
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,089,546 sharesKRXDART:20241218000118Canonical exit: 18 Mar 2025 (T+90)
- ShareKRXDART:20240723000109Canonical exit: 21 Oct 2024 (T+90)
- ShareKRXDART:20240718000063Canonical exit: 16 Oct 2024 (T+90)
- 10,900 sharesKRXDART:20240703000078Canonical exit: 1 Oct 2024 (T+90)
- 10,900 sharesKRXDART:20231020000240Canonical exit: 18 Jan 2024 (T+90)
- 10,900 sharesKRXDART:20220908000537Canonical exit: 7 Dec 2022 (T+90)
- 10,900 sharesKRXDART:20211230000424Canonical exit: 30 Mar 2022 (T+90)
8 of 8 declarations